Four-Year Clinical Follow-Up After Implantation of the Endeavor Zotarolimus-Eluting Stent: ENDEAVOR I, the First-in-Human Study
- 22 October 2007
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 100 (8) , S56-S61
- https://doi.org/10.1016/j.amjcard.2007.08.023
Abstract
No abstract availableKeywords
Funding Information
- Sanofi
- Medtronic
This publication has 13 references indexed in Scilit:
- Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary StentsNew England Journal of Medicine, 2007
- Randomized, Double-Blind, Multicenter Study of the Endeavor Zotarolimus-Eluting Phosphorylcholine-Encapsulated Stent for Treatment of Native Coronary Artery LesionsCirculation, 2006
- Two-Year-Plus Follow-Up of a Paclitaxel-Eluting Stent in De Novo Coronary Narrowings (TAXUS I)The American Journal of Cardiology, 2005
- Four-Year Angiographic and Intravascular Ultrasound Follow-Up of Patients Treated With Sirolimus-Eluting StentsCirculation, 2005
- Molecular Basis of Restenosis and Drug-Eluting StentsCirculation, 2005
- Maintenance of Long-Term Clinical Benefit With Sirolimus-Eluting Coronary StentsCirculation, 2005
- Evaluation of the Medtronic (Driver) cobalt-chromium alloy coronary stent systemThe American Journal of Cardiology, 2005
- Bench to BedsideCirculation, 2001
- Multicenter evaluation of the phosphorylcholinecoated biodivYsio stent in short de novo coronary lesions: The SOPHOS studyInternational Journal of Cardiovascular Interventions, 2000
- Cell Cycle ProgressionCirculation, 1998